Form DEF 14A Spruce Biosciences For: 9 April
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Spruce Biosciences Inc (SPRB)
Spruce Biosciences Inc stock price live, this page displays NASDAQ SPRB stock exchange data. View the SPRB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Spruce Biosciences Inc real time stock price chart below.
What Is the Spruce Biosciences Inc Stock Price Today?
The Spruce Biosciences Inc stock price today is 69.3200.
What Is the Stock Symbol for Spruce Biosciences Inc?
The stock ticker symbol for Spruce Biosciences Inc is SPRB.
Is SPRB the Same as $SPRB?
$SPRB is a common way to refer to the Spruce Biosciences Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Spruce Biosciences Inc Trade On?
Spruce Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Spruce Biosciences Inc a Good Stock to Buy?
Determining whether Spruce Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Spruce Biosciences Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRB quote. (ISIN: US85209E2081)
What Is the Spruce Biosciences Inc Stock Price Today?
The Spruce Biosciences Inc stock price today is 69.3200.
What Is the Stock Symbol for Spruce Biosciences Inc?
The stock ticker symbol for Spruce Biosciences Inc is SPRB.
Is SPRB the Same as $SPRB?
$SPRB is a common way to refer to the Spruce Biosciences Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Spruce Biosciences Inc Trade On?
Spruce Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Spruce Biosciences Inc a Good Stock to Buy?
Determining whether Spruce Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Spruce Biosciences Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SPRB quote. (ISIN: US85209E2081)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
66.8200
71.4600
52 wk Range
4.2750
240.0000
SPRB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
66.820071.4600
52 wk Range
4.2750240.0000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SPRB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
198.2500
Upside
+185.99%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 424B5 Spruce Biosciences Inc For: 9 March
- Investing.com
- Form DEF 14A Spruce Biosciences For: 9 April
- Investing.com
- Form 8K Spruce Biosciences Inc For: 20 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sleeping patterns. In addition, the company develops SPR202 for the treatment of Congenital Adrenal Hyperplasia (CAH), a chronic and potentially life-threatening rare disease with no cure. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize various pharmaceutical compounds. It also has a collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize Tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.
Spruce Biosciences Inc SWOT Analysis
Strategic Horizons | Learn about Spruce's expansion into MDD and PCOS treatments, diversifying beyond CAH and potentially reshaping the company's market position and valuation |
Financial Health | Discover Spruce's $70M cash position, runway through 2025, and efficient cash management, balanced against rapid cash burn and market cap challenges |
Market Dynamics | Delve into the competitive landscape of CAH treatment, with Spruce Biosciences vying against Neurocrine's crinecerfont in a market of 20,000-30,000 U.S. patients |
Tildacerfont Trials | Explore the pivotal CAHmelia-204 and CAHptain-205 trials, testing tildacerfont's efficacy in reducing glucocorticoid doses while maintaining androgen control in CAH patients |
Compare SPRB to Peers and Sector
Metrics to compare | SPRB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | −3.4x | −0.5x | |
PEG Ratio | −0.05 | −0.09 | 0.00 | |
Price / Book | 2.2x | 15.1x | 2.6x | |
Price / LTM Sales | - | 20.9x | 3.2x | |
Upside (Analyst Target) | 172.9% | 56.8% | 45.7% | |
Fair Value Upside | Unlock | 2.7% | 4.8% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 198.2500
(+185.99% Upside)
Earnings
Latest Release
Mar 09, 2026
EPS / Forecast
-11.29 / -0.15
Revenue / Forecast
-- / 250K
People Also Watch
FAQ
What Is the Spruce (SPRB) Stock Price Today?
The Spruce stock price today is 69.3200 USD.
What Stock Exchange Does Spruce Trade On?
Spruce is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Spruce?
The stock symbol for Spruce is "SPRB."
What Is the Spruce Market Cap?
As of today, Spruce market cap is 93.0400M USD.
What Is Spruce's Earnings Per Share (TTM)?
The Spruce EPS (TTM) is -50.8298.
When Is the Next Spruce Earnings Date?
Spruce will release its next earnings report on Nov 17, 2025.
From a Technical Analysis Perspective, Is SPRB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Spruce Stock Split?
Spruce has split 1 times.
How Many Employees Does Spruce Have?
Spruce has 8 employees.
What is the current trading status of Spruce (SPRB)?
As of Apr 16, 2026, Spruce (SPRB) is trading at a price of 69.3200 USD, with a previous close of 67.8000 USD. The stock has fluctuated within a day range of 66.8200 USD to 71.4600 USD, while its 52-week range spans from 4.2750 USD to 240.0000 USD.
What Is Spruce (SPRB) Price Target According to Analysts?
The average 12-month price target for Spruce is 198.2500 USD, with a high estimate of 283 USD and a low estimate of 140 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +185.99% Upside potential.
What Is the SPRB After Hours Price?
SPRB's last after hours stock price is 67.5000 USD, the stock has decreased by -1.8200, or -2.6300%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.